Work

Evaluation of sacituzumab-induced severe or febrile neutropenia and G-CSF utilization and cost for advanced HER2- breast cancer.

Year: 2025
Type: article
Study design: Observational Study
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4410809735
FWCI:
Cites:
Cited by:
Related to: 10